« Return to News | Awards & Advancement

Mahoney becomes CEO and president of Boston Scientific

Friday, November 2, 2012 11:52 AM

Boston Scientific, a global developer, manufacturer and marketer of medical devices, has named Michael F. Mahoney its new CEO and president. Mahoney succeeds interim CEO William H. (Hank) Kucheman. Mahoney has also been appointed to the Boston Scientific board of directors. 

Mahoney has more than 24 years of healthcare experience. He joined Boston Scientific as president in October 2011. For the past year, his responsibilities have focused on the oversight of cardiac rhythm management (CRM), endoscopy (GI and pulmonary) and numerous corporate functions.

Prior to joining Boston Scientific, Mahoney held several senior positions at Johnson & Johnson, most recently worldwide chairman of the medical devices and diagnostics (MD&D) division, overseeing 50,000 employees and seven franchises. Prior to joining Johnson & Johnson, Mahoney served as president and CEO of Global Healthcare Exchange (GHX), a provider of supply chain solutions and services. He began his career at General Electric Medical Systems, where he spent 12 years successfully leading various GE Medical Systems business units in diagnostic imaging, cardiology and healthcare information technology. 

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

February 25

Analysts: With market anticipation of Quintiles IPO, other CROs could soon file to go public

National Clinical Trial Network aims to link sponsors, minority patients for trials and access to new therapies

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

March

Sites rate the best
sponsors of 2013
Largest survey response ever puts Biogen Idec, Forest Labs, Bayer at top

As CRO industry
turns 30, a look back
at modest beginnings
Phenomenal growth, strategic partnering highlight evolution
of CROs

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

February

Sized out of big deals,
mid-tier CROs still thriving
Finding market niches, strategies to stay vital in changing research enterprise

Industry leaders embrace disruptive innovations
Despite resistance to change, many exploring data sharing, open-source collaboration

Already a subscriber?
Log in to your digital subscription.

Purchase the February issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.